CHO-MIF Contamination Detection in Antibody Production

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing anti-MIF antibodies are challenged by the contamination of CHO-MIF, which is produced by Chinese hamster ovary (CHO) cells and can bind to the antibodies, making it difficult to achieve highly pure antibody preparations.

Innovation Solution

A highly sensitive detection method using monoclonal rabbit anti-CHO-MIF antibodies is developed to detect CHO-MIF complexes and free soluble CHO-MIF, allowing for effective purification and ensuring the production of highly pure anti-MIF antibodies by incorporating a quality control step in the production process.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If CHO cells are used for producing anti-MIF antibodies, then productivity is improved, but CHO-MIF contaminations are generated that bind to the antibodies and reduce purity

Engineering Contradiction:
Improveantibody production efficiencyVSAvoidantibody purity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent applies the extraction principle by removing the harmful CHO-MIF contaminations from the antibody preparation through specific detection and purification methods. The monoclonal rabbit anti-CHO-MIF antibodies are used to specifically bind and remove CHO-MIF complexes and free soluble CHO-MIF from the preparation, thereby extracting the contaminating substance while preserving the desired anti-MIF antibodies.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent uses monoclonal rabbit anti-CHO-MIF antibodies as an intermediary substance to detect and remove CHO-MIF contaminations. These intermediary antibodies specifically bind to CHO-MIF, forming detectable complexes that enable the removal of contaminants without directly affecting the target anti-MIF antibodies being produced.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If detection sensitivity is increased to detect low levels of CHO-MIF, then measurement precision is improved, but device complexity increases

Engineering Contradiction:
ImproveCHO-MIF detection sensitivityVSAvoiddetection method complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent uses monoclonal rabbit anti-CHO-MIF antibodies that specifically copy or recognize the CHO-MIF structure, enabling highly sensitive detection through specific antigen-antibody binding. This specific recognition allows detection at very low concentrations (down to 0.03125 ppm) through standard immunoassay techniques without requiring complex instrumentation.

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The patent achieves high detection sensitivity by optimizing parameters such as antibody concentration, incubation time, and detection conditions. The use of monoclonal antibodies with high affinity for CHO-MIF, combined with optimized assay conditions, enables detection at extremely low concentrations while maintaining relatively simple procedural steps.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method enables the detection of CHO-MIF contaminations down to 0.03125 ppm, significantly improving the purity of anti-MIF antibodies and ensuring they are free from antigen/antibody complexes, thereby enhancing the quality of final antibody preparations.

Implementation Method 1

A highly sensitive detection method using monoclonal rabbit anti-CHO-MIF antibodies is developed to detect CHO-MIF complexes and free soluble CHO-MIF

Methodology Applied
Scientific EffectAntigen-antibody binding:

Data Source

PatentUS10626166B2Detection of CHO-MIF contaminations
Publication Date: 2020.04.21 BAXALTA GMBH
  • US10626166B2 patent drawing
  • US10626166B2 patent drawing
  • US10626166B2 patent drawing

AI summary

The invention concerns a detection method to enable the detection of complexes formed between antibodies and antigen which is endogenous to the production cell line, e.g. CHO MIF in a final product.